Submitted by Anonymous (not verified) on 10 February 2026 - 9:30
Human medicines European public assessment report (EPAR): Piasky, crovalimab, Date of authorisation: 22/08/2024, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Piasky, crovalimab, Date of authorisation: 22/08/2024, Revision: 3, Status: Authorised